Not sure how they have come up with the patient only being on MPL for 9 months.
Cohort 1
Announcement 6 January all 6 patients had been on the for 29 days of dosing
Cohort 2
Announcement 20 February 2023 first patient dosed
Announcement 28 April 2023 MND Trial successfully completes cohort 2
So when did the patient actually pass away if they had only for 9.5 months if they came from cohort 2 and with all patients in this cohort fully doesnt by 6 January 2023 that would mean they must have passed away by end of October 2023.
Or are my maths out or have PAA got it wrong
Not sure how they have come up with the patient only being on...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.005(2.86%) |
Mkt cap ! $71.26M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $35.10K | 195.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 262502 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 23783 | 2 |
View Market Depth
| Last trade - 11.13am 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
17.5¢ |
Change
0.005 ( 2.78 %) |
||||
| Open | High | Low | Volume | ||
| 18.0¢ | 18.0¢ | 17.5¢ | 72984 | ||
| Last updated 11.14am 22/05/2024 ? | |||||
| PAA (ASX) Chart |